News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–10
Matches
10
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

10 matching headlines

Ticker or company: IX1Main company stories
Clear
Latest

finance.yahoo.com Earnings

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected veterinary diagnostics portfolio and tapping into an underassessed companion-animal heart disease market. We'll now …

Main company 🇩🇪 Germany
Read at finance.yahoo.com
Sharemaestro market context Price below Trend Line 51 weeks +21.6% · Next-week setup negative 33.7% IX1 stored weekly price path from 8 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Main company 🇩🇪 Germany

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

IX1 main company
Sharemaestro market context Price below Trend Line 51 weeks +21.6% · Next-week setup negative 33.7% IX1 stored weekly price path from 8 Aug 2025 to 14 Aug 2026
finance.yahoo.com Market update Main company 🇩🇪 Germany

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

New test brings quantitative cardiac assessment for cats and dogs into everyday workflows WESTBROOK, Maine, August 11, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst™ proBNP Test, the first and only dual-species, …

IX1 main company
Sharemaestro market context Price below Trend Line 51 weeks +21.6% · Next-week setup negative 33.7% IX1 stored weekly price path from 8 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context